Micafungin Sodium

Micafungin Sodium - Names and Identifiers

Name	sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5-(4-(pe
Synonyms	FK 463 CS-705 Mycamine Funguard MYCAMINE FUNGUARD Micafungin Sodium Micafungin sodium micafungin sodium Impurity Micafungin SodiuM(FK-463, MycaMine) 1-[(4R,5R)-4,5-Dihydroxy-N2-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]pneuMocandin A0 MonosodiuM Salt sodium 5-((1S,2S)-2-((2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5-(4-(pe
CAS	208538-73-2
EINECS	810-840-7

Micafungin Sodium - Physico-chemical Properties

Molecular Formula	C56H72N9NaO23S
Molar Mass	1294.28
Melting Point	>180°C (dec.)
Solubility	H2O : 80 mg/mL DMSO : 30 mg/mL
Appearance	Solid
Color	White to Off-White
Storage Condition	Keep in dark place,Sealed in dry,Store in freezer, under -20°C
Stability	Hygroscopic
Use	Micafungin sodium a cyclic hexapeptide echinocandin lipopeptide.
Target	1,3-beta-D-glucan synthesis
In vitro study	Micafungin is an antifungal agent that does not inhibit bacteria. Although it does not directly inhibit bacteria, it can improve the survival rate of G. mellonella. Micafungin inhibits biofilm formation by blocking the synthesis of 1,3-β-D-glucan in Candida albicans.

Micafungin Sodium - Reference

Reference

1. Bazzi W, et al. The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa. Biofouling. 2013 Jul 23.2. Kai H, et al. Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigat us and its efficacy in murine infection models. J Antibiot (Tokyo). 2013 Jun 12.3. Ikeda F, Wakai Y, Matsumoto S, et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother. 2000;44(3):614-618.4. Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother. 2000;44(1):57-62.5. Mikamo H, Sato Y, Tamaya T. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. J Antimicrob Chemother. 2000;46(3):485-487.

Micafungin Sodium - Preparation solution concentration reference

	1mg	5mg	10mg
1 mM	0.774 ml	3.869 ml	7.738 ml
5 mM	0.155 ml	0.774 ml	1.548 ml
10 mM	0.077 ml	0.387 ml	0.774 ml
5 mM	0.015 ml	0.077 ml	0.155 ml

Last Update：2024-01-02 23:10:35

Micafungin Sodium - Cell Experiment

Each fungal isolate is incubated statically in yeast-maltose (YM) agar broth for 24 h at 30°C. Cryptococcus neoformans YC203 is grown in YM broth medium for 20 h at 30°C with shaking at 200 r.p.m. A cell suspension is prepared by washing the cultured cells once with sterile saline. A. fumigatus FP1305 is cultured on a potato dextrose agar (PDA) slant for 4 days, and spores are then harvested in sterile saline and collected by filtering through gauze. Antifungal activity against all isolates, with the exception of C. neoformans, is measured by the micro-broth dilution method in 96-well culture plates using RPMI 1640 medium supplemented with l-glutamine, but without sodium bicarbonate, and buffered to pH 7.0 with 0.165 m MOPS. ForC. neoformans, yeast nitrogen base-glucose (YNBD) medium is used. For the assay, the test microorganism is inoculated into each well to yield 1×105 CFU/well, and the plates are then incubated for 20 h or 48 h at 37°C. Two end points are determined by microscopic observation: MEC, which

Last Update：2023-08-16 21:32:38